

Microdosing
Paul Schrimpf
Microdosing delivers short, fact-driven reports that distill today’s trending healthcare topics, and add fresh perspectives that are grounded in expert insights and credible sources. For written reports and bibliographies, please visit www.md-pod.com.
Episodes
Mentioned books

Oct 20, 2022 • 8min
[Event: SMASH] Jeff Gronemeyer of Conversion Logix
Jeff Gronemeyer, VP at Conversion Logix, talks about senior living’s huge heart, and their new book, “Dating Your Way to Full Occupancy”.

Oct 19, 2022 • 9min
[Event: SMASH] Dan Hutson of Priya Living
Dan Hutson, head of marketing at Priya Living and long-time SMASH Advisory Board member joins us on this episode to introduce us to all things SMASH and what to expect this year. He also touches on his work at Priya Living which provides independent retirement communities people 65+, inspired by vibrant and colorful Indian culture.

Oct 19, 2022 • 2min
[Event: SMASH] An Intro to SMASH (Seniors Marketing and Sales)
SMASH is the leading sales and marketing conference for senior care. In addition to speaking at the event, we'll be collecting stories from other speakers and attendees in this series of Microdosing.

Oct 14, 2022 • 13min
[Op-Ed: Transformation] Datavant’s Recent Acquisition of …Datavant
"Water water everywhere and not a drop to drink" can sometimes be applied to healthcare data. It's in abundance, but it's fragmented. How does the industry bring it all together? Enter Datavant and Ciox, and why I love this new combo.
Link referenced in the episode:
https://datavant.com/resources/blog/the-fragmentation-of-health-data/

Oct 4, 2022 • 11min
[Op-Ed: Transformation] Siemens' New Image with Varian
Siemens acquired Varian in 2021, with the in intent that the combined companies would create a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global fight against cancer with significant potential for increased value creation. We agree, and think it signals a new generation of holistic imaging.

Sep 27, 2022 • 14min
[Op-Ed: Transformation] Teladoc Health's Myths and M&A
In a recent interview with Modern Healthcare, Jason Gorevic - CEO Tealdoc Health, said: “I think all the recent M&A is an example of our strategy that you can’t develop all the components brick by brick and assemble them in a way that is fast enough to stay ahead of the market and respond to consumer needs, and that’s part of the reason why we’ve been acquisitive historically.... We always look at the market in the future, and where we can accelerate our ability to deliver value for our clients faster with M&A, even as we continue to invest in innovation organically." So, if you're not paying attention to Teladoc Health now, you should. And if you really aren't paying attention, we'll bust a couple of common myths.

Sep 20, 2022 • 11min
[Op-Ed: Transformation] Walmart and Sowing the Seeds of Rural Healthcare
Walmart and UnitedHealth Group, two of the world's largest enterprises are teaming up to enable better care delivery through Walmart locations, beginning with many rural locations. How might this reshape rural care as we know it?

Sep 13, 2022 • 13min
[Op-Ed: Transformation] Is David Feinberg Cerner’s Oracle?
David Feinberg joined Cerner last year. Cerner then was subsequently acquired by Oracle. Oracle's founder and executive chairman, Larry Ellison, touts that Cerner is seeking to build a national EMR. What does it all mean? This episode takes a guess.

Sep 6, 2022 • 10min
[Op-Ed: Transformation] Mark Cuban’s Maverick Drug Company
Mark Cuban's "Cost Plus Drug Company" is on a mission to "disrupt the drug industry". When a big name makes big promises the healthcare industry normally gets either excited or cringes. However, I'm finding it's doing neither. In this episode, we share some thoughts and opinions as to why that is.

Aug 30, 2022 • 15min
[Op-Ed: Transformation] Amazon’s One + One Medical = Three
Amazon's latest acquisition of One Medical is another example of the constant momentum it's bringing into healthcare. I highlight how Amazon's entry into healthcare is showing greater potential than other non-healthcare players who are trying to break in.


